Vagal Nerve Stimulation as Therapeutic Approach on Metabolic Syndrome - Trial NCT05785117
Access comprehensive clinical trial information for NCT05785117 through Pure Global AI's free database. This phase not specified trial is sponsored by Rana Elbanna and is currently Recruiting. The study focuses on Metabolic Syndrome. Target enrollment is 70 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Rana Elbanna
Cairo University
Timeline & Enrollment
N/A
Mar 01, 2023
May 01, 2023
Primary Outcome
Emotional eating,Patient satisfaction measures,Cortisol level
Summary
Participants were randomly assigned to two groups prior to their second visit: the Vagus
 nerve stimulation group (VNS) and the circuit training program. The randomization processes
 were conducted in Excel utilizing a random-number generator. Prior to the second visit, each
 participants' target exercise heart rate ranges were determined. Vagus nerve stimulation
 group(VNS) Patients rested on their sides in a sitting position. Following regular
 disinfection of the stimulation locations, ear clips were placed in the ear region (auricular
 concha) at the stimulation site. The training regimen included ten different forms of
 resistance and aerobic exercises.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05785117
Device Trial